Detalhe da pesquisa
1.
Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza season.
Hum Vaccin Immunother
; 20(1): 2322196, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448394
2.
Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the influenza season 2021/22.
Influenza Other Respir Viruses
; 17(1): e13071, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36448240
3.
Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system.
Hum Vaccin Immunother
; 18(1): 1935170, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406896
4.
Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry.
Influenza Other Respir Viruses
; 16(1): 90-100, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520127
5.
Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.
Vaccine
; 38 Suppl 2: B56-B64, 2020 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31677950
6.
Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season.
Hum Vaccin Immunother
; 15(9): 2154-2158, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30897026
7.
Identifying Ontario geographic regions to assess adults who present to hospital with laboratory-defined conditions: a descriptive study.
CMAJ Open
; 7(4): E624-E629, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31641060